New hope for kids with bowel disease: testing a daily pill
NCT ID NCT07470879
Summary
This study is testing a daily pill called etrasimod to see if it can help control ulcerative colitis in children aged 2 to 12. Researchers will check if the medicine reduces bowel inflammation and symptoms over a year of treatment, and monitor its safety. Participants who complete the main study can choose to continue taking the medicine in a long-term follow-up study for up to four more years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLITIS, ULCERATIVE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Japanese Red Cross Kumamoto Hospital
Kumamoto, 861-8520, Japan
-
Juntendo University Hospital
Bunkyo-ku, Tokyo, 113-8431, Japan
-
Saitama Prefectural Children's Medical Center
Saitama-shi, Saitama, 330-8777, Japan
Conditions
Explore the condition pages connected to this study.